These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11362607)

  • 1. Hoffmann-LaRoche announces international compassionate treatment program for saquinavir.
    J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):32-4. PubMed ID: 11362607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitor: Roche lottery deadline July 21.
    AIDS Treat News; 1995 Jul; (no 226):4-5. PubMed ID: 11362614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lottery opens 2,000 slots for protease trial.
    AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European hurdles for saquinavir.
    J Int Assoc Physicians AIDS Care; 1995 Dec; 1(11):44. PubMed ID: 11363099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saquinavir: newest weapon in the antiviral arsenal.
    MacDougall DS
    J Int Assoc Physicians AIDS Care; 1996 Feb; 2(2):25-31. PubMed ID: 11363336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA antiviral advisory hearings on lamivudine (Epivir, 3TC), saquinavir (Invirase), stavudine (Zerit, d4T), November 6-8. Food and Drug Administration.
    AIDS Treat News; 1995 Oct; (no 233):4-5. PubMed ID: 11363038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor trials moving to next phase.
    AIDS Alert; 1995 Aug; 10(8):100-1. PubMed ID: 11362675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saquinavir gets accelerated approval.
    McGuire S
    Posit Aware; 1996; 7(1):8. PubMed ID: 11363135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Europe out of step with the US.
    Alcorn K
    J Int Assoc Physicians AIDS Care; 1996 Jan; 2(1):33-4. PubMed ID: 11363328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitor expanded access.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):3. PubMed ID: 11362689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III saquinavir clinical trials.
    J Int Assoc Physicians AIDS Care; 1995 Jun; 1(5):33. PubMed ID: 11362608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saquinavir (Roche protease inhibitor) at higher doses.
    AIDS Treat News; 1995 Sep; (no 231):5. PubMed ID: 11362870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roche and Merck begin expanded access programs for protease inhibitor drugs.
    Baker R
    BETA; 1995 Sep; ():4. PubMed ID: 11362890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Saquinavir thwarts resistance.
    AIDS Alert; 1995 Oct; 10(10):123. PubMed ID: 11362782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roche submits NDA for Invirase.
    J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saquinavir: combination shows survival benefit; new formulation trial recruiting.
    AIDS Treat News; 1996 May; (no 246):1-2. PubMed ID: 11363484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDA triple header. Food and Drug Administration.
    Smart T
    GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of refractory AIDS-related mucosal candidiasis after initiation of didanosine plus saquinavir.
    Zingman BS
    N Engl J Med; 1996 Jun; 334(25):1674-5. PubMed ID: 8628377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.